Related Experiment Video
Updated: Jun 24, 2026
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Therapeutic strategies for inhibiting invasion in glioblastoma
Jan Drappatz1, Andrew D Norden, Patrick Y Wen
1Center for Neuro-Oncology, Dana Farber Cancer Institute, 44 Binney Street, Boston MA 02115, USA. jdrappatz@partners.org
Abstract:
Glioblastomas are the most common and lethal form of malignant primary brain tumors. Although some progress has been made, the impact of recent advances in multimodality therapies on clinical outcome has been disappointing, with a median survival of less than 15 months. A major challenge in patients with glioblastomas is the propensity of the tumor to invade into adjacent brain tissue. Invasive tumor cells escape surgical removal and, because of their reduced proliferation rate and increased resistance to apoptosis, they are relatively resistant to radiation therapy and chemotherapy. Recently, there has been important progress in understanding the molecular determinants of glioma invasion and migration. This review will summarize some of the therapeutic strategies for inhibiting invasion in glioblastomas.
Insights
Glioblastomas are aggressive brain tumors with poor prognoses. This review explores therapeutic strategies targeting glioma invasion, a key factor in treatment resistance and poor outcomes.
Area of Science:
- Neuro-oncology
- Cancer biology
- Molecular medicine
Background:
- Glioblastomas are the most lethal primary brain tumors, with median survival under 15 months despite multimodal therapies.
- Tumor invasion into adjacent brain tissue is a major challenge, leading to incomplete surgical resection and resistance to conventional treatments.
- Invasive glioma cells exhibit reduced proliferation and increased resistance to apoptosis, radiation, and chemotherapy.
Purpose of the Study:
- To review recent advancements in understanding the molecular mechanisms driving glioma invasion and migration.
- To summarize current and emerging therapeutic strategies aimed at inhibiting glioblastoma invasion.
Main Methods:
- Literature review of molecular determinants of glioma invasion.
- Analysis of therapeutic strategies targeting invasion pathways.
- Synthesis of findings on clinical implications for glioblastoma treatment.
Main Results:
- Significant progress has been made in identifying molecular factors that control glioma cell invasion and migration.
- Various therapeutic approaches are being investigated to specifically target and inhibit these invasion mechanisms.
- Understanding these pathways offers new avenues for improving treatment efficacy.
Conclusions:
- Targeting glioblastoma invasion is a critical strategy to improve patient outcomes.
- Further research into molecular determinants and targeted therapies holds promise for overcoming treatment resistance.
- Inhibition of invasion could enhance the effectiveness of surgery, radiation, and chemotherapy.
